LYMPHIR
Active substance: denileukin diftitox
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DENILEUKIN DIFTITOX 300 ug/2mL
United StatesActive
Marketing holder: Citius Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DENILEUKIN DIFTITOX · 300 ug/2mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12098-c691-7464-928e-e5b525710a69;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 52658-7777
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 52658-7777 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 52658-7777 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 52658-7777 · Verified 2026-10-09 · open in source